26.57
price up icon2.12%   0.655
 
loading

Inhibrx Biosciences Inc (INBX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
100.00%
-
0.10 - 0.10 -
Operating Expenses
14.25%
42.90
50.03 46.80 161.00 73.83
Operating Income/Loss
14.07%
-42.90
-49.93 -46.80 -160.90 -73.83
Nonoperating Income/Loss
119.87%
-0.41
2.063 2.933 2,018.91 -4.885
Income/Loss From Continuing Operations Before Tax
9.51%
-43.31
-47.87 -43.86 1,858.01 -78.71
Income Tax Expense/Benefit
-
- - 0.002 -
Income/Loss From Continuing Operations After Tax
9.51%
-43.31
-47.87 -43.86 1,858.01 -78.71
Net Income/Loss
9.51%
-43.31
-47.87 -43.86 1,858.01 -78.71
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6,805%
15.47
0.224 15.47 14.62 54.55
Diluted Average Shares
9,390%
15.47
0.163 15.47 14.81 54.55
Basic Earnings Per Share
44.33%
-2.80
-5.03 -2.84 127.10 -1.44
Diluted Earnings Per Share
37.36%
-2.80
-4.47 -2.84 125.48 -1.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.88
price up icon 1.45%
$84.49
price up icon 0.81%
$25.03
price down icon 7.60%
$103.63
price down icon 0.75%
$132.75
price up icon 0.27%
biotechnology ONC
$300.00
price down icon 2.86%
자본화:     |  볼륨(24시간):